David Lee, MD
Dermatology · Damascus, MDNPI 1427263441
Payments from drug & device makers
Across 136 payments — averaging $20.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$232
- AbbVie$225
- Pfizer$206
- Sanofi$205
- Novartis$199
- Galderma Laboratories, L.p.$191
- plus $2K from 24 others
What the payments were for
- Food & beverage$2,761100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 10 | $232 |
| AbbVie(2 entities) | 11 | $225 |
| Pfizer | 10 | $206 |
| Sanofi | 6 | $205 |
| Novartis | 10 | $199 |
| Galderma Laboratories, L.p. | 12 | $191 |
| LEO Pharma Inc. | 8 | $144 |
| VYNE Pharmaceuticals Inc. | 5 | $143 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $126 |
| Johnson & Johnson | 5 | $113 |
| Gilead | 1 | $97 |
| Almirall LLC | 5 | $92 |
| Amgen | 5 | $84 |
| Bristol Myers Squibb | 4 | $70 |
| Organon | 5 | $51 |
| Lilly USA, LLC | 2 | $50 |
| E.r. Squibb & Sons, L.L.C. | 3 | $50 |
| Strata Skin Sciences, Inc. | 5 | $48 |
| Dermavant Sciences, Inc. | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Sebela Pharmaceuticals Inc. | 3 | $44 |
| Dermira, Inc. | 2 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $40 |
| Kerecis Limited | 1 | $40 |
| EPI Health, LLC | 2 | $40 |
| UCB, Inc. | 2 | $38 |
| Merz North America, Inc. | 1 | $29 |
| Promius Pharma LLC | 1 | $29 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
How this compares
$2,761 in reported general payments places this provider in the 50th percentile of 306 dermatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 14 | $53,305 |
| Ivermectin | 12 | $4,093 |
| Clobetasol Propionate | 61 | $3,137 |
| Cephalexin | 61 | $1,766 |
| Betamethasone Dipropionate | 51 | $1,400 |
| Triamcinolone Acetonide | 128 | $912 |
| Clindamycin Phosphate | 18 | $428 |
| Minoxidil | 29 | $394 |
| Fluocinonide | 12 | $327 |
| Doxycycline Hyclate | 26 | $307 |
| Ketoconazole | 15 | $300 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 20 | $267 |
| Hydrocortisone | 15 | $139 |
| Mupirocin | 14 | $98 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $43 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Damascus
- Benjamin LockshinSilver Spring$6.6M
- Shawn KwatraBaltimore$2.4M
- Robert WeissHunt Valley$2.3M
- Rebecca KazinChevy Chase$1.7M
- Chesahna Kindred WeaverMarriottsville$1.4M
- Valerie CallenderGlenn Dale$822K
- Oanh LauringNottingham$763K
- Lloyd MillerBaltimore$752K
- Ronald PrussickN Bethesda$630K
- Pantea TamjidiChevy Chase$541K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.